Sangui's IVD (in-vitro diagnostic) kits cleared for US marketing:
This article was originally published in Clinica
Sangui Biotech has received FDA clearance for two of its in-vitro diagnostic ELISA kits which detect the presence of adrenocorticotropic (ACTH) hormone and calcitonin. ACTH is an indicator of adrenal cortex function and calcitonin is used for evaluating thyroid and calcium metabolism.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.